The GRANDIOSA study (‘Growth, ALlergy and NeuroDevelopment in Infants On hydrolySed formulA’) started in late 2022 and is conducted in Umeå and Malmö. The purpose of the study is to determine the effects of two novel protein hydrolysates on infants’ growth, neurological development, allergies, gastrointestinal symptoms and other health outcomes. GRANDIOSA is a blinded, placebo-controlled, […]
Read More